Introduction
============

DNA microarrays have been recently widely employed in studies on breast cancer encompassing research on breast cancer cell lines and resected tumour tissues. Two directions of these studies seem to be especially spectacular and promising: the studies of the Norwegian/Stanford group that led to the recognition of several distinct molecular classes of breast cancers \[[@B1],[@B2]\] and the studies of a group at the Netherlands Cancer Institute, which brought identification of a 70-gene prognostic profile for patients with node-negative breast cancer \[[@B3],[@B4]\]. The results of those studies indicate that gene expression analysis by DNA microarrays may help the understanding of the molecular background underlying development and progression of breast cancer as well as providing a clinically useful tool for more personalized treatment \[reviewed in: \[[@B5]\]\]. It seems clear that a multi-gene approach will prove more useful and informative than currently used analysis of single markers.

Since the identification of two major predisposing genes, BRCA1 and BRCA2, and broad application of genetic testing, significant numbers of mutation carriers have been identified worldwide among breast cancer patients. This allowed further studies in order to estimate clinical features of those specific breast cancer cases. Some indications are accumulating that mutation-linked breast cancer may be a clinically distinct entity from the majority of malignant breast tumours. Among the characteristics of BRCA1 tumours are: earlier age of manifestation, high tumour grade, low oestrogen receptor content and elevated lymphocyte infiltration. In addition, these cases are often characterized by high proliferative activity, resulting in tumours with pushing margins and high mitotic index \[[@B6]-[@B12]\]. The data concerning survival in BRCA1 mutation carriers are confusing. There are intriguing observations that despite adverse prognostic indications, patients with BRCA1 mutations have survival rates similar to or even better than patients with sporadic breast cancer \[\[[@B13]-[@B15]\], own unpublished data\]. The long-term aim of our study is an attempt to elucidate the molecular basis underlying described discrepancies by comparing gene expression profiles of BRCA1-associated hereditary breast cancer and sporadic breast cancer cases. The first attempt to compare hereditary versus sporadic breast cancers by DNA microarray analysis was published by Hedenfalk et al., who used cDNA microarrays containing 6512 cDNA clones \[[@B16]\]. In our study we used HG U133 Plus 2.0 Gene Chip (Affymetrix), allowing detection of over 47,000 transcripts. We also attempted to make a more careful selection of tumour specimens, which were chosen exclusively from among ER(-) cases. Our group of tumours was also more uniform according to histopathology; only ductal carcinomas and medullary carcinomas, all grade 3, were analysed.

Materials and methods
=====================

Tissue samples
--------------

Frozen surgical specimens of breast cancer and adjacent normal breast tissue were obtained from the Pomeranian Medical Academy in Szczecin. Only tissues from patients without preceding chemotherapy were used for microarray experiments. For this initial study we chose seven cancer tissues from women with germline mutation in the BRCA1 gene and seven samples of sporadic breast cancer. Three cases had mutation C61G in exon 5, one at 4153delA in exon 11, and three harboured the 5382insC mutation in exon 20. Sporadic cases were obtained from women without a family history of breast/ovarian cancer, in which, additionally, the three most common BRCA1 mutations in Poland were excluded by genetic tests. Eight cases were diagnosed as grade 3 medullary or atypical medullary carcinoma, and 5 cases were grade 3 ductal carcinomas. All tumours were ER negative (immunohistochemistry on paraffin-embedded material). The percentage of cancer cells within tumour specimens was estimated by a pathologist; in the majority of samples it ranged from 70% to 90%, while in 3 samples it was approx. 50%. In addition, we analysed six samples of unchanged glandular tissue surrounding the tumour and obtained during mastectomy. The lack of tumour samples from BRCA2 mutation carriers in our study reflects the specificity of the mutational spectrum in BRCA genes in Central-Eastern Europe, where BRCA2 mutations are very rare (it was estimated by sequencing that BRCA2 mutations account for only about 5% of all BRCA1 and BRCA2 mutations found in Polish families with a strong familial history of breast/ovarian cancer \[[@B17]\]). In total we analysed 14 tumour samples and 6 normal breast samples.

RNA isolation
-------------

20-40 mg of frozen tissue was placed in a lysing solution (4M guanidine thiocyanate, 25 mM sodium citrate, 0.5% sodium N-laurylsarcosinate, 0.1M β-mercaptoethanol) and homogenized with Lysing Matrix D in a FastPrep instrument (QBioGene). Total RNA was extracted from the supernatant according to \[[@B18]\]. RNA cleanup and simultaneous on-column digestion of DNA traces with DNAse I (Qiagen) was done using the RNeasy Mini Kit (Qiagen), according to the manufacturer\'s instructions. RNA quantity was estimated with the ND-1000 Spectrophotometer (NanoDrop Technologies). RNA quality was controlled by microcapillary electrophoresis measurements in the Agilent 2100 Bioanalyzer using the RNA 6000 Nano LabChip Kit and analysed with RNA Integrity Number software (Agilent).

Oligonucleotide microarrays
---------------------------

We used HG U133 Plus 2.0 Gene Chip oligonucleotide arrays (Affymetrix). The hybridization target was prepared according to recommendations of microarray manufacturer. Briefly: 8 μg of total RNA was used for synthesis of double stranded cDNA, half volume of cDNA was used for synthesis of biotynylated cRNA with the BioArray High Yield RNA Transcript Labeling Kit (Enzo Diagnostics). Both cDNA and cRNA were purified with Gene Chip Sample Cleanup Module (Affymetrix). 16g of cRNA was fragmented and hybridized to the microarray for 16h at 45°C. After washing and staining microarrays were scanned with GeneChip Scanner 3000 (Affymetrix).

Statistical analysis of microarray data
---------------------------------------

Data were obtained using GCOS 1.2 software (Affymetrix). The preprocessing was performed by Robust Multi-Array Analysis (RMA). Hierarchical clustering, Principal Component Analysis (PCA) and supervised comparisons were carried out using GeneSpring 7.2 software (Silicon Genetics). For selection of genes differentially expressed between breast cancer and normal breast tissue we used the parametric Welch test. False Discovery Rate was estimated by Benjamini-Hochberg algorithm. For selection of genes differentially expressed between hereditary and sporadic breast cancer we used the Bioconductor *limma*package, based on linear models with empirical Bayesian approach. This method provides stable results even when the number of analysed arrays is small.

Quantitative RT-PCR
-------------------

Quantitative RT-PCR analysis was performed using the ABI 7700 Sequence Detection System and dedicated software (Applied Biosystems). The reactions were performed using the MasterAmp Real-Time RT-PCR Kit (Epicentre), according to the manufacturer\'s recommendations. Primers for the SYBR Green system were designed using Primer3 online software <http://frodo.wi.mit.edu/cgi-bin/prime-r3/primer3_www.cgi>. All results were normalised to the expression of the reference gene, eukaryotic translation initiation factor 4 gamma 2 (EIF4G2), which appeared to be equally transcribed in all tissues analysed by microarrays. Primer specificity was verified by sequencing of selected RT-PCR products for each gene. Sequences of the PCR primer pairs used for each gene are shown in Table [1](#T1){ref-type="table"}.

###### 

Primers used for quantitative RT-PCR

  ----------------------------------------------------------------------------------
  Gene     Oligonucleotide   Sequence                                 product size
  -------- ----------------- ---------------------------------------- --------------
  SEPHS2   forward primer\   5\'-GGAAAGGAGGACCTGCAACCA-3\'\           154 bp
           reverse primer    5\'-ACCAGGAATCTGCCGCAAAAG-3\'            

                                                                      

  TOB1     forward primer\   5\'-ttgtttctacgacatggtattgcattta-3\'\    182 bp
           reverse primer    5\'-caagtattcgtacattttaattccaccact-3\'   

                                                                      

  EIFG2    forward primer\   5\'-GCAAGGCTTTGTTCCAGGTGA-3\'\           100 bp
           reverse primer    5\'-AGGCTTTGGCTGGTTCTTTAGTCA-3\'         
  ----------------------------------------------------------------------------------

Results
=======

Unsupervised analysis of obtained data set
------------------------------------------

We performed Principal Component Analysis (PCA) to determine the major sources of variability in our data (Fig. [1](#F1){ref-type="fig"}). PCA is an unsupervised algorithm, which, if performed \'on conditions\', is able to detect intrinsic similarities and differences in the gene expression profiles of analysed samples. Results may be graphically presented and the distances between the dots visualize the level of similarity/dissimilarity between particular samples. It can be seen that the difference in gene expression profile between breast cancer tissue and normal breast tissue is large and is easily recognized by that unsupervised algorithm (normal-tumour difference was responsible for the sample subdivision by the first component, which accounted for 24.06% of total variance). Using a supervised method of data analysis we found that this precise separation of cancer versus normal tissues in PCA may be ascribed to the differential expression of 8,063 genes (Welch test, Benjamini-Hochberg correction for multiple comparisons, FDR\<0.05). In contrast, the difference between hereditary and sporadic breast cancer samples cannot be recognized by PCA, suggesting that the difference in gene expression profile between those two types of breast cancer is not very powerful. Samples obtained from normal glandular breast tissue clustered closely together, while tumours were much more dispersed. By unsupervised analysis we were unable to disclose any differences between hereditary and sporadic tumours; they were not visible also when only cancer samples were subjected to decomposition into principal components (data not shown).

![**Principal component analysis (PCA) performed on the whole set of 20 samples**. The tumor (red and blue) vs. normal (green) difference is clearly visible within the 1^st^component, which accounted for 24.06% of total variance. PCA is unable to reveal a difference between hereditary (red) and sporadic tumors (blue).](1897-4287-4-1-28-1){#F1}

Genes differentiating between hereditary and sporadic breast tumours
--------------------------------------------------------------------

As the unsupervised method showed that the distance between hereditary and sporadic tumours is not large and taking into account the limited number of samples in our analysis, we chose a supervised algorithm with a good balance of sensitivity and specificity of analysis. We used the *limma*package \[[@B19]\], a Bayesian method based on linear modelling with moderated t-statistic.

We selected 100 genes best differentiating between the two analysed groups, ranked according to the statistical power of the expression change (Table [2](#T2){ref-type="table"}.). Four times more probe sets were down-regulated in hereditary tumours (78 probesets) in comparison to up-regulated transcripts (22 probe sets). Down-regulated genes showed an average decrease of 1.35 to 5-fold, up-regulated genes were changed by a factor of 1.2-7.8. Among the first hundred genes selected by *limma*the most prominent classes consisted of genes connected with regulation of transcription (19 genes), metabolism (12 genes), protein synthesis and degradation (10 genes), cellular signalling (8 genes), cell proliferation and death (6 genes) and DNA and RNA replication and processing (5 genes).

###### 

Genes differentiating between hereditary, BRCA1-positive breast cancers and sporadic tumours, selected by *limma*. Genes are ordered according to the fold change value and grouped into functional classes (according to Gene Ontology annotation, <http://www.geneontology.org/>)

  Affy_ID                                  Gene Symbol      Gene Title                                                                                                                      Fold change BRCA1(+)vs. sporadic   *limma*rank
  ---------------------------------------- ---------------- ------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- -------------
  **Down-regulated in BRCA1(+)**                                                                                                                                                                                               
                                                                                                                                                                                                                               
   **Cell proliferation and death**                                                                                                                                                                                            
                                                                                                                                                                                                                               
   202704_at                               TOB1             transducer of ERBB2, 1                                                                                                          0.364                              75
                                                                                                                                                                                                                               
   243031_at                               RTN4             Reticulon 4                                                                                                                     0.421                              71
                                                                                                                                                                                                                               
   1556049_at                              RTN4             reticulon 4                                                                                                                     0.506                              46
                                                                                                                                                                                                                               
   215070_x\_at                            RABGAP1          RAB GTPase activating protein 1                                                                                                 0.731                              97
                                                                                                                                                                                                                               
   **Cell signalling**                                                                                                                                                                                                         
                                                                                                                                                                                                                               
   1553986_at                              RASEF            RAS and EF-hand domain containing                                                                                               0.25                               49
                                                                                                                                                                                                                               
   244181_at                               PIK3R1           Phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)                                                                     0.381                              80
                                                                                                                                                                                                                               
   238176_at                               RAPGEF2          Rap guanine nucleotide exchange factor (GEF) 2                                                                                  0.461                              58
                                                                                                                                                                                                                               
   229261_at                               SOS1             Son of sevenless homolog 1 (Drosophila)                                                                                         0.565                              92
                                                                                                                                                                                                                               
   215992_s\_at                            RAPGEF2          Rap guanine nucleotide exchange factor (GEF) 2                                                                                  0.583                              90
                                                                                                                                                                                                                               
   207822_at                               FGFR1            fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)                                          0.704                              82
                                                                                                                                                                                                                               
   **DNA and RNA**                                                                                                                                                                                                             
                                                                                                                                                                                                                               
   233007_at                               XRCC5            X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa)   0.667                              22
                                                                                                                                                                                                                               
   230651_at                               THOC2            THO complex 2                                                                                                                   0.414                              45
                                                                                                                                                                                                                               
   243908_at                               ZNF638           Zinc finger protein 638                                                                                                         0.531                              17
                                                                                                                                                                                                                               
   218356_at                               FTSJ2            FtsJ homolog 2 (E. coli)                                                                                                        0.699                              57
                                                                                                                                                                                                                               
   **Metabolism**                                                                                                                                                                                                              
                                                                                                                                                                                                                               
   239545_at                               CAS1             O-acetyltransferase                                                                                                             0.331                              26
                                                                                                                                                                                                                               
   238563_at                               TPRT             Trans-prenyltransferase                                                                                                         0.351                              14
                                                                                                                                                                                                                               
   215316_at                               HIBADH           3-hydroxyisobutyrate dehydrogenase                                                                                              0.539                              30
                                                                                                                                                                                                                               
   200961_at                               SEPHS2           selenophosphate synthetase 2                                                                                                    0.576                              72
                                                                                                                                                                                                                               
   202282_at                               HADH2            hydroxyacyl-Coenzyme A dehydrogenase, type II                                                                                   0.585                              2
                                                                                                                                                                                                                               
   238813_at                               ALAS2            Aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia)                                                          0.607                              7
                                                                                                                                                                                                                               
   232127_at                               CLCN5            Chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease)                                                                  0.626                              33
                                                                                                                                                                                                                               
   218124_at                               RetSat           all-trans-13,14-dihydroretinol saturase                                                                                         0.63                               67
                                                                                                                                                                                                                               
   **Protein synthesis and degradation**                                                                                                                                                                                       
                                                                                                                                                                                                                               
   240146_at                               CAPZA2           Capping protein (actin filament) muscle Z-line, alpha 2                                                                         0.267                              28
                                                                                                                                                                                                                               
   235138_at                               PUM2             Vacuolar protein sorting 35 (yeast)                                                                                             0.287                              25
                                                                                                                                                                                                                               
   1560926_at                              PPP4R2           Protein phosphatase 4, regulatory subunit 2                                                                                     0.323                              88
                                                                                                                                                                                                                               
   1554638_at                              ZFYVE16          zinc finger, FYVE domain containing 16                                                                                          0.43                               56
                                                                                                                                                                                                                               
   238303_at                               SIMP             Source of immunodominant MHC-associated peptides                                                                                0.432                              35
                                                                                                                                                                                                                               
   232216_at                               YME1L1           YME1-like 1 (S. cerevisiae)                                                                                                     0.443                              87
                                                                                                                                                                                                                               
   239175_at                               AFTIPHILIN       Aftiphilin protein                                                                                                              0.486                              4
                                                                                                                                                                                                                               
   222499_at                               MRPS16           mitochondrial ribosomal protein S16                                                                                             0.537                              62
                                                                                                                                                                                                                               
   202347_s\_at                            HIP2             huntingtin interacting protein 2                                                                                                0.565                              8
                                                                                                                                                                                                                               
   214843_s\_at                            USP33            ubiquitin specific protease 33                                                                                                  0.695                              61
                                                                                                                                                                                                                               
   **Regulation of transcription**                                                                                                                                                                                             
                                                                                                                                                                                                                               
   1559949_at                              TRPS1            Trichorhinophalangeal syndrome I                                                                                                0.199                              69
                                                                                                                                                                                                                               
   210282_at                               ZNF198           zinc finger protein 198                                                                                                         0.25                               44
                                                                                                                                                                                                                               
   202600_s\_at                            NRIP1            nuclear receptor interacting protein 1                                                                                          0.282                              70
                                                                                                                                                                                                                               
   243792_x\_at                            PTPN13           Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)                                    0.36                               43
                                                                                                                                                                                                                               
   222320_at                               HRPT2            Hyperparathyroidism 2 (with jaw tumor)                                                                                          0.403                              11
                                                                                                                                                                                                                               
   222544_s\_at                            WHSC1L1          Wolf-Hirschhorn syndrome candidate 1-like 1                                                                                     0.408                              18
                                                                                                                                                                                                                               
   222313_at                               CNOT2            CCR4-NOT transcription complex, subunit 2                                                                                       0.412                              15
                                                                                                                                                                                                                               
   216022_at                               WNK1             WNK lysine deficient protein kinase 1                                                                                           0.414                              31
                                                                                                                                                                                                                               
   235409_at                               MGA              MAX gene associated                                                                                                             0.443                              40
                                                                                                                                                                                                                               
   212881_at                               PIAS4            protein inhibitor of activated STAT, 4                                                                                          0.448                              55
                                                                                                                                                                                                                               
   227798_at                               SMAD1            SMAD, mothers against DPP homolog 1 (Drosophila)                                                                                0.45                               16
                                                                                                                                                                                                                               
   213766_x\_at                            GNA11            guanine nucleotide binding protein (G protein), alpha 11 (Gq class)                                                             0.487                              39
                                                                                                                                                                                                                               
   217550_at                               ATF6             Activating transcription factor 6                                                                                               0.518                              94
                                                                                                                                                                                                                               
   222180_at                               YES1             V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1                                                                              0.604                              98
                                                                                                                                                                                                                               
   218955_at                               BRF2             BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like                                                  0.635                              83
                                                                                                                                                                                                                               
   212079_s\_at                            MLL              myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)                                                      0.666                              29
                                                                                                                                                                                                                               
   213944_x\_at                            GNA11            guanine nucleotide binding protein (G protein), alpha 11 (Gq class)                                                             0.693                              59
                                                                                                                                                                                                                               
   **Other**                                                                                                                                                                                                                   
                                                                                                                                                                                                                               
   1559496_at                              \-\--            \-\--                                                                                                                           0.284                              5
                                                                                                                                                                                                                               
   234032_at                               \-\--            PRO1550                                                                                                                         0.289                              19
                                                                                                                                                                                                                               
   242343_x\_at                            ZNF518           Zinc finger protein 518                                                                                                         0.309                              68
                                                                                                                                                                                                                               
   221543_s\_at                            SPFH2            SPFH domain family, member 2                                                                                                    0.322                              6
                                                                                                                                                                                                                               
   204148_s\_at                            ZP3 /// POMZP3   zona pellucida glycoprotein 3 (sperm receptor) /// POM (POM121 homolog, rat) and ZP3 fusion                                     0.324                              65
                                                                                                                                                                                                                               
   232489_at                               FLJ10287         hypothetical protein FLJ10287                                                                                                   0.33                               1
                                                                                                                                                                                                                               
   236841_at                               FLJ25222         CXYorf1-related protein                                                                                                         0.334                              60
                                                                                                                                                                                                                               
   227931_at                               \-\--            MRNA; cDNA DKFZp686D22106 (from clone DKFZp686D22106)                                                                           0.382                              54
                                                                                                                                                                                                                               
   238706_at                               PAPD4            PAP associated domain containing 4                                                                                              0.386                              63
                                                                                                                                                                                                                               
   221542_s\_at                            SPFH2            SPFH domain family, member 2                                                                                                    0.398                              24
                                                                                                                                                                                                                               
   231878_at                               MVP              Major vault protein                                                                                                             0.412                              12
                                                                                                                                                                                                                               
   1564637_a\_at                           FLJ38426         hypothetical protein FLJ38426                                                                                                   0.47                               52
                                                                                                                                                                                                                               
   228971_at                               \-\--            \-\--                                                                                                                           0.476                              95
                                                                                                                                                                                                                               
   235970_at                               MLR1             transcription factor MLR1                                                                                                       0.485                              73
                                                                                                                                                                                                                               
   230871_at                               DHX30            DEAH (Asp-Glu-Ala-His) box polypeptide 30                                                                                       0.5                                99
                                                                                                                                                                                                                               
   233228_at                               ZNF407           Zinc finger protein 407                                                                                                         0.508                              48
                                                                                                                                                                                                                               
   237157_at                               EVE1             SH3 domain protein D19                                                                                                          0.519                              9
                                                                                                                                                                                                                               
   215385_at                               FTO              Fatso                                                                                                                           0.527                              41
                                                                                                                                                                                                                               
   222496_s\_at                            FLJ20273         RNA-binding protein                                                                                                             0.528                              42
                                                                                                                                                                                                                               
   219001_s\_at                            WDR32            WD repeat domain 32                                                                                                             0.533                              76
                                                                                                                                                                                                                               
   235927_at                               \-\--            \-\--                                                                                                                           0.542                              86
                                                                                                                                                                                                                               
   1569813_at                              STRN             striatin, calmodulin binding protein                                                                                            0.549                              66
                                                                                                                                                                                                                               
   240939_x\_at                            \-\--            \-\--                                                                                                                           0.557                              79
                                                                                                                                                                                                                               
   222642_s\_at                            TMEM33           transmembrane protein 33                                                                                                        0.558                              81
                                                                                                                                                                                                                               
   213984_at                               SCC-112          SCC-112 protein                                                                                                                 0.565                              37
                                                                                                                                                                                                                               
   234488_s\_at                            GCL /// GMCL1L   germ cell-less homolog 1 (Drosophila)                                                                                           0.619                              100
                                                                                                                                                                                                                               
   201297_s\_at                            MOBK1B           MOB1, Mps One Binder kinase activator-like 1B (yeast)                                                                           0.626                              96
                                                                                                                                                                                                                               
   238660_at                               WDFY3            WD repeat and FYVE domain containing 3                                                                                          0.663                              13
                                                                                                                                                                                                                               
   212602_at                               WDFY3            WD repeat and FYVE domain containing 3                                                                                          0.708                              47
                                                                                                                                                                                                                               
   212602_at                               WDFY3            WD repeat and FYVE domain containing 3                                                                                          0.708                              47
                                                                                                                                                                                                                               
  **Up-regulated in BRCA1(+)**                                                                                                                                                                                                 
                                                                                                                                                                                                                               
   **Cell proliferation and death**                                                                                                                                                                                            
                                                                                                                                                                                                                               
   203139_at                               DAPK1            death-associated protein kinase 1                                                                                               1.896                              74
                                                                                                                                                                                                                               
   209074_s\_at                            TU3A             TU3A protein                                                                                                                    2.865                              89
                                                                                                                                                                                                                               
   **Cell signalling**                                                                                                                                                                                                         
                                                                                                                                                                                                                               
   227125_at                               IFNAR2           Interferon (alpha, beta and omega) receptor 2                                                                                   1.791                              23
                                                                                                                                                                                                                               
   204613_at                               PLCG2            phospholipase C, gamma 2 (phosphatidylinositol-specific)                                                                        2.083                              20
                                                                                                                                                                                                                               
   **DNA and RNA**                                                                                                                                                                                                             
                                                                                                                                                                                                                               
   203805_s\_at                            FANCA            Fanconi anemia, complementation group A /// Fanconi anemia, complementation group A                                             2.056                              93
                                                                                                                                                                                                                               
   **Immune response**                                                                                                                                                                                                         
                                                                                                                                                                                                                               
   211530_x\_at                            HLA-G            HLA-G histocompatibility antigen, class I, G                                                                                    1.575                              38
                                                                                                                                                                                                                               
   205067_at                               IL1B             interleukin 1, beta                                                                                                             1.809                              78
                                                                                                                                                                                                                               
   205671_s\_at                            HLA-DOB          major histocompatibility complex, class II, DO beta                                                                             2.37                               3
                                                                                                                                                                                                                               
   206407_s\_at                            CCL13            chemokine (C-C motif) ligand 13                                                                                                 2.89                               10
                                                                                                                                                                                                                               
   234764_x\_at                            IGLC2            Ig lambda chain V-region (VL-AIG) /// Immunoglobulin lambda variable 3-21                                                       6.297                              51
                                                                                                                                                                                                                               
   **Metabolism**                                                                                                                                                                                                              
                                                                                                                                                                                                                               
   222046_at                               ARS2             arsenate resistance protein ARS2                                                                                                1.475                              77
                                                                                                                                                                                                                               
   204428_s\_at                            LCAT             lecithin-cholesterol acyltransferase                                                                                            1.767                              27
                                                                                                                                                                                                                               
   208964_s\_at                            FADS1            fatty acid desaturase 1                                                                                                         1.9                                64
                                                                                                                                                                                                                               
   1555745_a\_at                           LYZ              lysozyme (renal amyloidosis)                                                                                                    7.787                              36
                                                                                                                                                                                                                               
   **Regulation of transcription**                                                                                                                                                                                             
                                                                                                                                                                                                                               
   221010_s\_at                            SIRT5            sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae                                                  1.378                              32
                                                                                                                                                                                                                               
   206090_s\_at                            DISC1            disrupted in schizophrenia 1                                                                                                    1.72                               85
                                                                                                                                                                                                                               
   **Other**                                                                                                                                                                                                                   
                                                                                                                                                                                                                               
   237883_at                               \-\--            Transcribed locus                                                                                                               1.316                              84
                                                                                                                                                                                                                               
   213938_at                               CAST             CAZ-associated structural protein                                                                                               1.339                              53
                                                                                                                                                                                                                               
   1561759_at                              \-\--            Homo sapiens, clone IMAGE:5276804, mRNA                                                                                         1.369                              50
                                                                                                                                                                                                                               
   218600_at                               MGC10986         hypothetical protein MGC10986                                                                                                   1.46                               21
                                                                                                                                                                                                                               
   226410_at                               LOC348180        hypothetical protein LOC348180                                                                                                  1.694                              91
                                                                                                                                                                                                                               
   241383_at                               LOC201181        similar to hypothetical protein A930006D11                                                                                      2.053                              34

Figure [2](#F2){ref-type="fig"} shows that use of a set of 100 genes for hierarchical clustering results in almost perfect classification of hereditary and sporadic tumour samples. Only one sporadic sample falls into the branch of hereditary cases.

![**Hierarchical clustering of samples, based on 100 genes differentiating between hereditary and sporadic breast tumors**. Colors on the right bar code for: regulation of transcription (orange), cell signalling (blue), cell proliferation and death (black), DNA and RNA replication transcription and processing (red), cellular metabolism (yellow), protein synthesis and degradation (green), immune response (violet) and other (grey). It may be seen, that most prominent cluster of genes upregulated in hereditary tumors consists of genes engaged to immune response, what probably reflects lymphocyte infiltrate of those tumors.](1897-4287-4-1-28-2){#F2}

Within a set of 100 genes selected in our study, we found genes coding for proteins known to be interacting with the BRCA1 pathway, such as Fanconi Anemia complementation group A gene (FANCA, increased 2-fold) and *XRCC5*(50% decrease), which are both engaged in double-strand break repair. FANCA protein is a component of the multi-subunit FA complex which takes part in sensing and/or regulation of the DNA damage response. The FA complex activates FANCD2 protein which is further targeted to the BRCA1 nuclear loci. Inactivation of the FA/BRCA pathway leads to chromosomal instability, due to impaired DNA repair \[[@B20]\]. DNA repair protein XRCC5 (80 kDa Ku autoantigen) is the DNA-binding component of the DNA-dependent protein kinase, and functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining \[[@B21]\].

The *TOB1*gene (transducer of ERBB2 gene, decreased in hereditary tumours) encodes a member of the tob/btg1 family of anti-proliferative proteins that have the potential to regulate cell growth, and is probably engaged in several human tumours (breast, lung, thyroid) \[[@B22]-[@B25]\]. This protein inhibits T cell proliferation and transcription of cytokines and cyclins. This is the only gene from Hedenfalk\'s list \[[@B15]\] that appears within the first 100 genes selected by *limma*.

Another interesting gene is selenophosphate synthetase 2 (*SEPHS2*, decreased in hereditary tumours). This protein encodes an enzyme that synthesizes selenophosphate from selenide and ATP. Selenophosphate is the selenium donor used to synthesize selenocysteine, which is co-translationally incorporated into selenoproteins at inframe UGA codons. This protein itself contains a selenocysteine residue in its predicted active site. It has been proposed that the effects of selenium in preventing cancer and neurological disorders may be mediated by selenium-binding proteins \[[@B26]\].

The most prominent among genes up-regulated in hereditary carcinomas is a group of immune response genes (5 genes). On the contrary, no immunological genes are found in the list of down-regulated genes. This may reflect a common feature of BRCA1-linked breast cancer, i.e. the inflammatory state and lymphocyte infiltrate of a tumour. It is especially striking as all our tumour samples were inspected by a pathologist, and only pieces of tumour mass without a visible inflammatory state were taken for microarray experiments. Thus we conclude that this immunological imprint must be very prominent in BRCA1(+) breast cancer.

Validation of microarray results by Q RT-PCR
--------------------------------------------

We selected *TOB1*and *SEPHS2*genes (see Table [1](#T1){ref-type="table"}) for further analysis by quantitative RT-PCR. We examined the expression level of these genes in 12 tumours with mutations in BRCA1 and 16 tumours without mutation. The results of this analysis were concordant with the microarray results: both genes seem to be down-regulated in BRCA1-linked tumours, when compared to sporadic ones. The difference in expression level of *TOB1*and *SEPHS2*genes in BRCA1-linked tumours versus BRCA1 negative tumours was statistically significant (p-value for *TOB1*: 0.003, for *SEPHS2*: 0.005, Kolmogorov-Smirnov test, Fig. [3](#F3){ref-type="fig"}).

![**Real-time quantitative PCR validation of microarray results for two selected genes**. Box-and-whisker plot represent median and quartile values, with non-outlier range denoted by whiskers and outliers marked by asterisks and circles. Statistical comparison was performed by Kolmogorov-Smirnov test.](1897-4287-4-1-28-3){#F3}

Discussion
==========

Our preliminary study was done on a relatively small number of cases; however it may be informative, as the samples were chosen carefully. In all previous microarray studies on breast cancer it was observed that the most striking difference in the gene expression profile is connected with oestrogen receptor status. Initially it was stated that ER(+) and ER(-) breast cancers represent distinct categories of breast tumours \[[@B27],[@B28]\]. More detailed studies performed on a larger set of samples revealed further subtypes, e.g. luminal A and luminal B subtypes among ER(+) tumours and at least two subtypes: ERBB2+ and \'basal\' within and ER(-) group \[Perou et al., 2000; Sorlie et al., 2001\]. Alternatively, another subdivision of ER(-) cases was proposed by Farmer at al., who claim two subgroups: \'basal\', characterized by oestrogen and androgen receptors negativity and expression of cytokeratins 5 and 17, and \'molecular apocrine\', negative for ER and positive for AR \[[@B29]\]. It was also shown previously that BRCA1 mutation-linked breast cancer tissues cluster within a \'basal\' subtype \[[@B30]\]. However, these specific cases account only for the minority of \'basal\' tumours; thus the genes that are differentially expressed between basal and other subgroups do not necessarily reflect a difference in the biology of hereditary (BRCA1-linked) and sporadic carcinomas. Moreover, a set of genes differentiating between breast cancer subtypes in the studies of Perou and Sorlie was selected from genes that are stably expressed in the biopsy specimens, taken from the same tumour before and after chemotherapy. This allowed the construction of so-called \'molecular portraits\' of each tumour, but may have eliminated some significant genes that could be suppressed by chemotherapy. In our study we analyse only tumours that have not been subjected to neoadjuvant chemotherapy. To reduce, at least partially, the sources of variability that are not linked to BRCA1 status, we decided to analyse only ER(-) tumour samples.

The aim of our study was to reveal a set of genes differentially expressed between BRCA1 mutation-linked and sporadic breast cancer. Similar study have been performed by Hedenfalk et al., who analysed seven sporadic, seven BRCA1- and eight BRCA2-linked breast cancers and published a set of 51 differentially expressed genes. We tried to retrieve information about expression of those 51 genes from HG U133 Plus 2.0 Gene Chip used in our study. However, due to the incompatibility of both types of DNA microarrays, we were able to find expression data only for 40 genes (represented by 88 probesets). This set of genes was unable to discriminate between sporadic and hereditary cases from our cohort (not shown). This may be caused by shortening of the original list of genes and the fact that the set of 51 genes was selected by comparison of BRCA1 and BRCA2 tumours with the sporadic ones, all of them of rather mixed histopathology, grade and ER status. Of the genes from Hedenfalk\'s list only one (TOB1) is represented, at the 62nd position, in our list of 100 genes selected by *limma*.

It should be mentioned that Jazaeri et al., who analysed a cohort of hereditary and sporadic ovarian cancers, found by the unsupervised method of data analysis that BRCA1 and BRCA2 tumours localize separately from each other, while sporadic cases were placed by the algorithm between these two groups, some of them being closer to BRCA1 tumours, others to BRCA2 tumours \[[@B31]\]. This result confirms all previous observations that BRCA1 and BRCA2 mutation-linked carcinomas are different entities, and suggests that at least in some sporadic cases BRCA1 or BRCA2 pathways may be truncated, thus accounting for BRCA1-like and BRCA2-like sporadic tumours. It should be verified whether this hypothesis applies also to breast cancer. Interestingly, in our group of samples Jazaeri\'s set of genes performed better than a set published by Hedenfalk \[[@B15]\] (not shown).

Prediction of BRCA status in patients with breast cancer on the basis of clinical and molecular features would be very useful for genetic counselling and for cost-reduction of genetic screening \[[@B32],[@B33]\]. It was shown recently by Lakhani et al., 2005, that ER status together with immunochemistry for some markers of \'basal\' subtype (CK14, CK5/6, CK17 and osteonectin) is better able to predict BRCA1 mutation status in breast cancer patients than previously used criteria \[[@B34]\]. Although it must be experimentally proven, we believe that among 100 genes selected by *limma*some markers may appear to improve the specificity of prediction of BRCA1 status.
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